Soleus Capital
Overview
Soleus Capital is a healthcare investment firm located in Greenwich, CT which manages hedge, private equity and credit funds primarily focused on the innovative areas of life sciences, including biotech, medtech, diagnostics, and genomics . The firm invests across the healthcare lifecycle from developmental-stage companies through commercial companies . Soleus Capital's primary investment strategy seeks superior risk-adjusted returns over time by investing in the healthcare sector .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Crystalys Therapeutics | Jul 2026 | Series B | Co-investor |
| Candid Therapeutics, Inc. | Mar 2026 | PIPE | Co-investor |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
| Longeviti Neuro Solutions | Aug 2025 | Strategic | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
